DHL COLDCHAIN offers fast, reliable and flexible solutions designed for the Life Science Industry

The life science industry increasingly demands for Europe-wide transport solutions which are able to guarantee product integrity. Being able to offer this, strengthens a global market position. Thus, DHL Freight has been developing the unique DHL COLDCHAIN network.

DHL COLDCHAIN supports its customers by efficient, flexible and most reliable transport solutions along the entire supply chain. By shaping this innovative solution across Europe, DHL Freight becomes the preferred logistics partner for the life science industry.

DHL comprises long-term experience and knowledge gathered by working for major life science companies for numerous years.DHL has been constantly listening to its customers in all major layers in the market sector, and learned their specific requirements and demands concerning transport solutions. Following these guidelines the DHL COLDCHAIN services have been developed. DHL COLDCHAIN is a dedicated, fully monitored and temperature controlled LTL network offering the best possible treatment for sensitive products of this market sector.

DHL COLDCHAIN meets all requirements of the industry in terms of temperature control, security and handling. Its services cover the range of refrigerated (2 – 8° Celsius) as well as controlled ambient products (2 – 25° Celsius).

International temperature controlled network
Throughout Europe, DHL Freight built the infrastructure for demanding products of pharmaceutical and life science industry. A fleet of refrigerated trucks is at your disposal at any time, and ensures the sensitive goods are constantly treated at the right temperature.

Throughout the journey, the temperature of the pharmaceuticals is continuously measured and transmitted via GPS.With our state of-the-art IT tools, this allows each customer to track the status and temperature of all shipments during the entire journey. In addition, all warehouses and cross docking stations are specifically equipped to guarantee continuous temperature control. Of course, they meet all GDP requirements (Good Distribution Practice). In the extension of DHL Freight network of branch offices and cross-docking stations, DHL COLDCHAIN provides the shortest possible lead-times. As an advantage, DHL COLDCHAIN is an LTL (less than truck load) service with fixed departure schedules. By these choices, our customers benefit from our flexibility and costeffectiveness. Even for smaller volumes.

Services

  • Unique DHL COLDCHAIN network across Europe and beyond
  • LTL consolidation service
  • Temperature controlled services for refrigerated (2 – 8° Celsius) as well as controlled ambient products (2 – 25° Celsius)
  • Top quality handling and security services
  • GPS security surveillance
  • Scheduled departures and deliveries
  • Short lead times
  • Central booking and administration
  • Online tracking & tracing
  • Temperature data recording

For further information, please contact:

DHL Freight
Life Science Competence Center
DHL Logistics (Switzerland) Ltd
St. Jakobs-Strasse 224
4052 Basle
Switzerland
Telephone +41 61 315 9191
www.dhl.ch

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...